TNFSF9 and neurodegenerative disease: Blocking CD137L signaling reduces the release of neuroinflammatory mediators, and CD137L knockout mice are largely prevented from developing neurodegenerative disease (Wong & Schwarz, 2020; Mak et al., 2019; Ma et al., 2013).